{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:19:40Z","timestamp":1788866380763,"version":"build-2803163510"},"reference-count":118,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:00:00Z","timestamp":1605312000000},"content-version":"vor","delay-in-days":227,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1074\/jbc.rev119.008897","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T18:44:23Z","timestamp":1583433863000},"page":"5152-5162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["The balance of protein farnesylation and geranylgeranylation during the progression of nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"295","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3236-6360","authenticated-orcid":false,"given":"Yue","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5574-423X","authenticated-orcid":false,"given":"Tian-Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7545-2234","authenticated-orcid":false,"given":"Meng-Fei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.REV119.008897_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.bi.65.070196.001325","article-title":"Protein prenylation: molecular mechanisms and functional consequences","volume":"65","author":"Zhang","year":"1996","journal-title":"Annu. Rev. Biochem"},{"key":"10.1074\/jbc.REV119.008897_bib2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrm.2015.11","article-title":"Protein prenylation: unique fats make their mark on biology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/jbc.REV119.008897_bib3","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1084\/jem.20121806","article-title":"Altered protein prenylation in Sertoli cells is associated with adult infertility resulting from childhood mumps infection","volume":"210","author":"Wang","year":"2013","journal-title":"J. Exp. Med"},{"key":"10.1074\/jbc.REV119.008897_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/path.5131","article-title":"Geranylgeranyl diphosphate synthase (GGPPS) regulates non-alcoholic fatty liver disease (NAFLD)-fibrosis progression by determining hepatic glucose\/fatty acid preference under high-fat diet conditions","volume":"246","author":"Liu","year":"2018","journal-title":"J. Pathol"},{"key":"10.1074\/jbc.REV119.008897_bib5","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/cvr\/cvy042","article-title":"Geranylgeranyl pyrophosphate synthase facilitates the organization of cardiomyocytes during mid-gestation through modulating protein geranylgeranylation in mouse heart","volume":"114","author":"Chen","year":"2018","journal-title":"Cardiovasc. Res"},{"key":"10.1074\/jbc.REV119.008897_bib6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/nyas.12016","article-title":"Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals","volume":"1281","author":"Masuoka","year":"2013","journal-title":"Ann. N.Y. Acad. Sci"},{"key":"10.1074\/jbc.REV119.008897_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-med-090514-013832","article-title":"Liver cancer: connections with obesity, fatty liver, and cirrhosis","volume":"67","author":"Marengo","year":"2016","journal-title":"Annu. Rev. Med"},{"key":"10.1074\/jbc.REV119.008897_bib8","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v18.i19.2300","article-title":"Animal models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"18","author":"Takahashi","year":"2012","journal-title":"World J. Gastroenterol"},{"key":"10.1074\/jbc.REV119.008897_bib9","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41467-020-14450-6","article-title":"Liver governs adipose remodelling via extracellular vesicles in response to lipid overload","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.REV119.008897_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.freeradbiomed.2006.10.045","article-title":"Antioxidant and antiplatelet effects of rosuvastatin in a hamster model of prediabetes","volume":"42","author":"Miersch","year":"2007","journal-title":"Free Radic. Biol. Med"},{"key":"10.1074\/jbc.REV119.008897_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/156800906775471743","article-title":"Anti-cancer therapy: targeting the mevalonate pathway","volume":"6","author":"Swanson","year":"2006","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1074\/jbc.REV119.008897_bib12","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.2741\/2401","article-title":"Protein isoprenylation in biology and disease: general overview and perspectives from studies with genetically engineered animals","volume":"12","author":"Perez-Sala","year":"2007","journal-title":"Front. Biosci"},{"key":"10.1074\/jbc.REV119.008897_bib13","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1074\/jbc.270.11.6221","article-title":"Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro","volume":"270","author":"James","year":"1995","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.REV119.008897_bib14","doi-asserted-by":"crossref","first-page":"11626","DOI":"10.1073\/pnas.97.21.11626","article-title":"RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody","volume":"97","author":"Baron","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.REV119.008897_bib15","first-page":"1905","article-title":"Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2\/TC21, transformation","volume":"10","author":"Carboni","year":"1995","journal-title":"Oncogene"},{"key":"10.1074\/jbc.REV119.008897_bib16","doi-asserted-by":"crossref","first-page":"14093","DOI":"10.1074\/jbc.272.22.14093","article-title":"Direct demonstration of geranylgeranylation and farnesylation of Ki-Ras in vivo","volume":"272","author":"Rowell","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.REV119.008897_bib17","doi-asserted-by":"crossref","first-page":"14459","DOI":"10.1074\/jbc.272.22.14459","article-title":"K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors","volume":"272","author":"Whyte","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.REV119.008897_bib18","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41594-019-0249-3","article-title":"GGTase3 is a newly identified geranylgeranyltransferase targeting a ubiquitin ligase","volume":"26","author":"Kuchay","year":"2019","journal-title":"Nat. Struct. Mol. Biol"},{"key":"10.1074\/jbc.REV119.008897_bib19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41557-019-0237-6","article-title":"Dual chemical probes enable quantitative system-wide analysis of protein prenylation and prenylation dynamics","volume":"11","author":"Storck","year":"2019","journal-title":"Nat. Chem"},{"key":"10.1074\/jbc.REV119.008897_bib20","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/oxfordjournals.jbchem.a022835","article-title":"Subcellular fractionation of polyprenyl diphosphate synthase activities responsible for the syntheses of polyprenols and dolichols in spinach leaves","volume":"128","author":"Sakaihara","year":"2000","journal-title":"J. Biochem"},{"key":"10.1074\/jbc.REV119.008897_bib21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1126\/science.aar5140","article-title":"Structure of the yeast oligosaccharyltransferase complex gives insight into eukaryotic N-glycosylation","volume":"359","author":"Wild","year":"2018","journal-title":"Science"},{"key":"10.1074\/jbc.REV119.008897_bib22","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1021\/acs.bioconjchem.7b00436","article-title":"Assembling glycan-charged dolichol phosphates: chemoenzymatic synthesis of a Haloferax volcanii N-glycosylation pathway intermediate","volume":"28","author":"Elharar","year":"2017","journal-title":"Bioconjug. Chem"},{"key":"10.1074\/jbc.REV119.008897_bib23","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/MCB.20.6.2158-2166.2000","article-title":"The branch point enzyme of the mevalonate pathway for protein prenylation is overexpressed in the ob\/ob mouse and induced by adipogenesis","volume":"20","author":"Vicent","year":"2000","journal-title":"Mol. Cell Biol"},{"key":"10.1074\/jbc.REV119.008897_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.ijo.0802189","article-title":"Dominant negative \u03b1-subunit of farnesyl- and geranylgeranyl-transferase I inhibits insulin-induced differentiation of 3T3-L1 pre-adipocytes","volume":"27","author":"Solomon","year":"2003","journal-title":"Int. J. Obes. Relat. Metab. Disord"},{"key":"10.1074\/jbc.REV119.008897_bib25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bone.2011.09.056","article-title":"Geranylgeranyl pyrophosphate stimulates PPAR\u03b3 expression and adipogenesis through the inhibition of osteoblast differentiation","volume":"50","author":"Weivoda","year":"2012","journal-title":"Bone"},{"key":"10.1074\/jbc.REV119.008897_bib26","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/jcb.23087","article-title":"The effects of direct inhibition of geranylgeranyl pyrophosphate synthase on osteoblast differentiation","volume":"112","author":"Weivoda","year":"2011","journal-title":"J. Cell Biochem"},{"key":"10.1074\/jbc.REV119.008897_bib27","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1074\/jbc.M110.190165","article-title":"An early response transcription factor, Egr-1, enhances insulin resistance in type 2 diabetes with chronic hyperinsulinism","volume":"286","author":"Shen","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.REV119.008897_bib28","doi-asserted-by":"crossref","first-page":"E2690","DOI":"10.3390\/ijms18122690","article-title":"Simvastatin inhibits cell proliferation and migration in human anaplastic thyroid cancer","volume":"18","author":"Chen","year":"2017","journal-title":"Int. J. Mol. Sci"},{"key":"10.1074\/jbc.REV119.008897_bib29","doi-asserted-by":"crossref","first-page":"20086","DOI":"10.1074\/jbc.M115.657742","article-title":"Lipid-induced muscle insulin resistance is mediated by GGPPS via modulation of the RhoA\/Rho kinase signaling pathway","volume":"290","author":"Tao","year":"2015","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.REV119.008897_bib30","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/j.1572-0241.2003.07659.x","article-title":"The natural history of nonalcoholic fatty liver disease: a clinical histopathological study","volume":"98","author":"Harrison","year":"2003","journal-title":"Am. J. Gastroenterol"},{"key":"10.1074\/jbc.REV119.008897_bib31","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"10.1074\/jbc.REV119.008897_bib32","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1074\/jbc.REV119.008897_bib33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/1471-2407-14-248","article-title":"GGPPS1 predicts the biological character of hepatocellular carcinoma in patients with cirrhosis","volume":"14","author":"Yu","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1074\/jbc.REV119.008897_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2005.11.014","article-title":"Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake","volume":"3","author":"Gong","year":"2006","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.REV119.008897_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2013.09.001","article-title":"Novel insights of dietary polyphenols and obesity","volume":"25","author":"Wang","year":"2014","journal-title":"J. Nutr. Biochem"},{"key":"10.1074\/jbc.REV119.008897_bib36","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/jcp.25469","article-title":"SCD1 alters long-chain fatty acid (LCFA) composition and its expression is directly regulated by SREBP-1 and PPAR\u03b3 1 in dairy goat mammary cells","volume":"232","author":"Yao","year":"2017","journal-title":"J. Cell Physiol"},{"key":"10.1074\/jbc.REV119.008897_bib37","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.REV119.008897_bib38","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/s41467-019-09152-7","article-title":"Sterol regulatory element binding protein 1 couples mechanical cues and lipid metabolism","volume":"10","author":"Bertolio","year":"2019","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.REV119.008897_bib39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejphar.2017.08.010","article-title":"Zoledronic acid, an FPPS inhibitor, ameliorates liver steatosis through inhibiting hepatic de novo lipogenesis","volume":"814","author":"Tang","year":"2017","journal-title":"Eur. J. Pharmacol"},{"key":"10.1074\/jbc.REV119.008897_bib40","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc2676","article-title":"The LKB1-AMPK pathway: metabolism and growth control in tumour suppression","volume":"9","author":"Shackelford","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.REV119.008897_bib41","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/hep.23535","article-title":"Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease","volume":"51","author":"Abdelmalek","year":"2010","journal-title":"Hepatology"},{"key":"10.1074\/jbc.REV119.008897_bib42","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"10.1074\/jbc.REV119.008897_bib43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0092-8674(88)90571-5","article-title":"Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes","volume":"53","author":"Almoguera","year":"1988","journal-title":"Cell"},{"key":"10.1074\/jbc.REV119.008897_bib44","first-page":"159","article-title":"High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis","volume":"4","author":"Lemoine","year":"1989","journal-title":"Oncogene"},{"key":"10.1074\/jbc.REV119.008897_bib45","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1073\/pnas.84.24.9228","article-title":"RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes","volume":"84","author":"Janssen","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.REV119.008897_bib46","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM198809013190901","article-title":"Genetic alterations during colorectal-tumor development","volume":"319","author":"Vogelstein","year":"1988","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.REV119.008897_bib47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/1523-1747.ep12371783","article-title":"Ras mutations in human melanoma: a marker of malignant progression","volume":"102","author":"Ball","year":"1994","journal-title":"J. Invest. Dermatol"},{"key":"10.1074\/jbc.REV119.008897_bib48","first-page":"5738","article-title":"Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung","volume":"48","author":"Rodenhuis","year":"1988","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.REV119.008897_bib49","first-page":"4682","article-title":"ras oncogenes in human cancer: a review","volume":"49","author":"Bos","year":"1989","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.REV119.008897_bib50","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1083\/jcb.200202009","article-title":"Activated K-Ras and H-Ras display different interactions with saturable nonraft sites at the surface of live cells","volume":"157","author":"Niv","year":"2002","journal-title":"J. Cell Biol"},{"key":"10.1074\/jbc.REV119.008897_bib51","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1158\/0008-5472.CAN-16-2925","article-title":"H-Ras and K-Ras oncoproteins induce different tumor spectra when driven by the same regulatory sequences","volume":"77","author":"Drosten","year":"2017","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.REV119.008897_bib52","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1128\/MCB.20.7.2475-2487.2000","article-title":"H-ras but not K-ras traffics to the plasma membrane through the exocytic pathway","volume":"20","author":"Apolloni","year":"2000","journal-title":"Mol. Cell Biol"},{"key":"10.1074\/jbc.REV119.008897_bib53","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/35070050","article-title":"GTP-dependent segregation of H-ras from lipid rafts is required for biological activity","volume":"3","author":"Prior","year":"2001","journal-title":"Nat. Cell Biol"},{"key":"10.1074\/jbc.REV119.008897_bib54","doi-asserted-by":"crossref","first-page":"35392","DOI":"10.1074\/jbc.M405924200","article-title":"Platelet-derived growth factor stimulates membrane lipid synthesis through activation of phosphatidylinositol 3-kinase and sterol regulatory element-binding proteins","volume":"279","author":"Demoulin","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.REV119.008897_bib55","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/01.RES.0000139956.42923.4A","article-title":"Vascular endothelial growth factor activation of sterol regulatory element binding protein: a potential role in angiogenesis","volume":"95","author":"Zhou","year":"2004","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.REV119.008897_bib56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/bj3490013","article-title":"Regulation of sterol regulatory-element binding protein 1 gene expression in liver: role of insulin and protein kinase B\/cAkt","volume":"349","author":"Fleischmann","year":"2000","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.REV119.008897_bib57","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.bbamcr.2011.09.017","article-title":"Akt acutely activates the cholesterogenic transcription factor SREBP-2","volume":"1823","author":"Luu","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.REV119.008897_bib58","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1038\/sj.onc.1208802","article-title":"PKB\/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP","volume":"24","author":"Porstmann","year":"2005","journal-title":"Oncogene"},{"key":"10.1074\/jbc.REV119.008897_bib59","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/onc.2015.179","article-title":"Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP","volume":"35","author":"Ricoult","year":"2016","journal-title":"Oncogene"},{"key":"10.1074\/jbc.REV119.008897_bib60","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1158\/0008-5472.CAN-10-4108","article-title":"Positive feedback loop between PI3K-Akt-mTORC1 signaling and the lipogenic pathway boosts Akt signaling: induction of the lipogenic pathway by a melanoma antigen","volume":"71","author":"Yamauchi","year":"2011","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.REV119.008897_bib61","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","article-title":"Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma","volume":"140","author":"Calvisi","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1074\/jbc.REV119.008897_bib62","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/gast.2002.31093","article-title":"3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis","volume":"122","author":"Kusama","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1074\/jbc.REV119.008897_bib63","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1073\/pnas.0908396107","article-title":"Targeting the protein prenyltransferases efficiently reduces tumor development in mice with K-RAS-induced lung cancer","volume":"107","author":"Liu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.REV119.008897_bib64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biopha.2015.12.017","article-title":"Statins inhibited the MIP-1\u03b1 expression via inhibition of Ras\/ERK and Ras\/Akt pathways in myeloma cells","volume":"78","author":"Tsubaki","year":"2016","journal-title":"Biomed. Pharmacother"},{"key":"10.1074\/jbc.REV119.008897_bib65","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1101\/gad.993902","article-title":"Distinct requirements for Ras oncogenesis in human versus mouse cells","volume":"16","author":"Hamad","year":"2002","journal-title":"Genes Dev"},{"key":"10.1074\/jbc.REV119.008897_bib66","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/35020106","article-title":"Genomic analysis of metastasis reveals an essential role for RhoC","volume":"406","author":"Clark","year":"2000","journal-title":"Nature"},{"key":"10.1074\/jbc.REV119.008897_bib67","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1038\/s41388-019-0794-6","article-title":"Inhibition of geranylgeranyl diphosphate synthase is a novel therapeutic strategy for pancreatic ductal adenocarcinoma","volume":"38","author":"Haney","year":"2019","journal-title":"Oncogene"},{"key":"10.1074\/jbc.REV119.008897_bib68","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1038\/ncomms7239","article-title":"Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis","volume":"6","author":"Wu","year":"2015","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.REV119.008897_bib69","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1172\/JCI30868","article-title":"GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer","volume":"117","author":"Sjogren","year":"2007","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.REV119.008897_bib70","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1128\/MCB.17.6.3449","article-title":"Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation","volume":"17","author":"Qiu","year":"1997","journal-title":"Mol. Cell Biol"},{"key":"10.1074\/jbc.REV119.008897_bib71","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1158\/0008-5472.CAN-10-3367","article-title":"MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase","volume":"71","author":"Cao","year":"2011","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.REV119.008897_bib72","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nrc2231","article-title":"Reflecting on 25 years with MYC","volume":"8","author":"Meyer","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.REV119.008897_bib73","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.yexcr.2004.10.019","article-title":"Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells","volume":"304","author":"Mazi\u00e8res","year":"2005","journal-title":"Exp. Cell Res"},{"key":"10.1074\/jbc.REV119.008897_bib74","doi-asserted-by":"crossref","first-page":"17974","DOI":"10.1074\/jbc.C000145200","article-title":"Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice","volume":"275","author":"Chen","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.REV119.008897_bib75","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ncb2936","article-title":"Metabolic control of YAP and TAZ by the mevalonate pathway","volume":"16","author":"Sorrentino","year":"2014","journal-title":"Nat. Cell Biol"},{"key":"10.1074\/jbc.REV119.008897_bib76","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.tcb.2015.11.004","article-title":"Control of YAP\/TAZ activity by metabolic and nutrient-sensing pathways","volume":"26","author":"Santinon","year":"2016","journal-title":"Trends Cell Biol"},{"key":"10.1074\/jbc.REV119.008897_bib77","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1101\/gad.274167.115","article-title":"The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation","volume":"30","author":"Aylon","year":"2016","journal-title":"Genes Dev"},{"key":"10.1074\/jbc.REV119.008897_bib78","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","article-title":"Hepatocyte TAZ\/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis","volume":"24","author":"Wang","year":"2016","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.REV119.008897_bib79","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrgastro.2014.25","article-title":"NAFLD. Metabolic make-up of NASH: from fat and sugar to amino acids","volume":"11","author":"Sookoian","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"key":"10.1074\/jbc.REV119.008897_bib80","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/01.ATV.0000163840.63685.0c","article-title":"Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins","volume":"25","author":"Arnaud","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.REV119.008897_bib81","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.26226","article-title":"Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease","volume":"58","author":"Begriche","year":"2013","journal-title":"Hepatology"},{"key":"10.1074\/jbc.REV119.008897_bib82","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tibs.2010.07.007","article-title":"Regulation of autophagy by ROS: physiology and pathology","volume":"36","author":"Scherz-Shouval","year":"2011","journal-title":"Trends Biochem. Sci"},{"key":"10.1074\/jbc.REV119.008897_bib83","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ncpgasthep0084","article-title":"Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease","volume":"2","author":"Sanyal","year":"2005","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol"},{"key":"10.1074\/jbc.REV119.008897_bib84","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature25486","article-title":"Mitochondria-lysosome contacts regulate mitochondrial fission via RAB7 GTP hydrolysis","volume":"554","author":"Wong","year":"2018","journal-title":"Nature"},{"key":"10.1074\/jbc.REV119.008897_bib85","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1042\/BST20120158","article-title":"Rab proteins of the endoplasmic reticulum: functions and interactors","volume":"40","author":"Ortiz Sandoval","year":"2012","journal-title":"Biochem. Soc. Trans"},{"key":"10.1074\/jbc.REV119.008897_bib86","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12974-016-0788-z","article-title":"Rab32 connects ER stress to mitochondrial defects in multiple sclerosis","volume":"14","author":"Haile","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1074\/jbc.REV119.008897_bib87","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.15252\/embj.201796463","article-title":"Rab35 GTPase recruits NDP52 to autophagy targets","volume":"36","author":"Minowa-Nozawa","year":"2017","journal-title":"EMBO J"},{"key":"10.1074\/jbc.REV119.008897_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/1043-2760(95)00180-8","article-title":"A model for farnesoid feedback control in the mevalonate pathway","volume":"7","author":"Weinberger","year":"1996","journal-title":"Trends Endocrinol. Metab"},{"key":"10.1074\/jbc.REV119.008897_bib89","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1210\/en.2011-0016","article-title":"Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation","volume":"152","author":"Weivoda","year":"2011","journal-title":"Endocrinology"},{"key":"10.1074\/jbc.REV119.008897_bib90","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.clinbiochem.2007.03.016","article-title":"Mevalonate pathway: a review of clinical and therapeutical implications","volume":"40","author":"Buhaescu","year":"2007","journal-title":"Clin. Biochem"},{"key":"10.1074\/jbc.REV119.008897_bib91","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.CIR.101.2.207","article-title":"Current perspectives on statins","volume":"101","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"10.1074\/jbc.REV119.008897_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(03)00239-9","article-title":"Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities","volume":"173","author":"Rosenson","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1074\/jbc.REV119.008897_bib93","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000156702","article-title":"Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma","volume":"78","author":"Graf","year":"2008","journal-title":"Digestion"},{"key":"10.1074\/jbc.REV119.008897_bib94","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrc.2016.76","article-title":"The interplay between cell signalling and the mevalonate pathway in cancer","volume":"16","author":"Mullen","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.REV119.008897_bib95","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cell.2018.10.032","article-title":"Boosting immunity by targeting post-translational prenylation of small GTPases","volume":"175","author":"Robert","year":"2018","journal-title":"Cell"},{"key":"10.1074\/jbc.REV119.008897_bib96","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2018.08.070","article-title":"The mevalonate pathway is a druggable target for vaccine adjuvant discovery","volume":"175","author":"Xia","year":"2018","journal-title":"Cell"},{"key":"10.1074\/jbc.REV119.008897_bib97","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3389\/fonc.2018.00394","article-title":"Mevalonate metabolism in cancer stemness and trained immunity","volume":"8","author":"Gruenbacher","year":"2018","journal-title":"Front. Oncol"},{"key":"10.1074\/jbc.REV119.008897_bib98","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drup.2016.02.001","article-title":"Could drugs inhibiting the mevalonate pathway also target cancer stem cells?","volume":"25","author":"Likus","year":"2016","journal-title":"Drug Resist. Updat"},{"key":"10.1074\/jbc.REV119.008897_bib99","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.2337\/db17-0077","article-title":"Rab8a deficiency in skeletal muscle causes hyperlipidemia and hepatosteatosis by impairing muscle lipid uptake and storage","volume":"66","author":"Chen","year":"2017","journal-title":"Diabetes"},{"key":"10.1074\/jbc.REV119.008897_bib100","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ccr.2005.03.004","article-title":"Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development","volume":"7","author":"Mijimolle","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.REV119.008897_bib101","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1172\/JCI43758","article-title":"Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice","volume":"121","author":"Khan","year":"2011","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.REV119.008897_bib102","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrc3151","article-title":"Targeting protein prenylation for cancer therapy","volume":"11","author":"Berndt","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.REV119.008897_bib103","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1200\/JCO.2004.10.112","article-title":"Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer","volume":"22","author":"Van Cutsem","year":"2004","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/jbc.REV119.008897_bib104","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1200\/JCO.2004.10.037","article-title":"Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer","volume":"22","author":"Rao","year":"2004","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/jbc.REV119.008897_bib105","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1182\/blood-2009-01-198093","article-title":"A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older","volume":"114","author":"Harousseau","year":"2009","journal-title":"Blood"},{"key":"10.1074\/jbc.REV119.008897_bib106","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1194\/jlr.R600004-JLR200","article-title":"Thematic review series: lipid posttranslational modifications. CAAX modification and membrane targeting of Ras","volume":"47","author":"Wright","year":"2006","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.REV119.008897_bib107","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1158\/1078-0432.CCR-14-3214","article-title":"Targeting RAS membrane association: back to the future for anti-RAS drug discovery?","volume":"21","author":"Cox","year":"2015","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/jbc.REV119.008897_bib108","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1074\/jbc.REV119.008897_bib109","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/hep.20671","article-title":"Statins and hepatotoxicity: focus on patients with fatty liver","volume":"41","author":"Chalasani","year":"2005","journal-title":"Hepatology"},{"key":"10.1074\/jbc.REV119.008897_bib110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nchembio0409-197","article-title":"Getting a handle on protein prenylation","volume":"5","author":"Hougland","year":"2009","journal-title":"Nat. Chem. Biol"},{"key":"10.1074\/jbc.REV119.008897_bib111","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2174\/156800909789057033","article-title":"Targeting the mevalonate pathway for improved anticancer therapy","volume":"9","author":"Fritz","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1074\/jbc.REV119.008897_bib112","first-page":"711","article-title":"Nitrogen-containing bisphosphonate mechanism of action","volume":"4","author":"Reszka","year":"2004","journal-title":"Mini Rev. Med. Chem"},{"key":"10.1074\/jbc.REV119.008897_bib113","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2407-6-60","article-title":"Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells","volume":"6","author":"Goffinet","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1074\/jbc.REV119.008897_bib114","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0022-2275(20)41388-4","article-title":"Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis","volume":"33","author":"Amin","year":"1992","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.REV119.008897_bib115","first-page":"759","article-title":"1-Hydroxy-3-(methylpentylamino)-propylidene-1,1-bisphosphonic acid as a potent inhibitor of squalene synthase","volume":"46","author":"Amin","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"10.1074\/jbc.REV119.008897_bib116","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1124\/jpet.110.175521","article-title":"Bisphosphonates induce autophagy by depleting geranylgeranyl diphosphate","volume":"337","author":"Wasko","year":"2011","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1074\/jbc.REV119.008897_bib117","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.bmc.2006.02.010","article-title":"Synthesis and biological activity of isoprenoid bisphosphonates","volume":"14","author":"Shull","year":"2006","journal-title":"Bioorg. Med. Chem"},{"key":"10.1074\/jbc.REV119.008897_bib118","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.bbrc.2006.12.094","article-title":"Digeranyl bisphosphonate inhibits geranylgeranyl pyrophosphate synthase","volume":"353","author":"Wiemer","year":"2007","journal-title":"Biochem. Biophys. Res. Commun"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925817486054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925817486054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.REV119.008897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T08:01:02Z","timestamp":1620028862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925817486054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":118,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0021925817486054"],"URL":"https:\/\/doi.org\/10.1074\/jbc.rev119.008897","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The balance of protein farnesylation and geranylgeranylation during the progression of nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.REV119.008897","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Zhao et al.","name":"copyright","label":"Copyright"}]}}